Editors for Medicine

We aim to publish significant translational research and clinical studies focused on improving human health. Our interests include, but are not limited to, the etiology, pathophysiology, diagnosis, genetics, prevention, and treatment of human disorders, as well as the biological, environmental and socioeconomic determinants of health which lead to changes in medical practice, population health and health policy. Read the latest research in this subject area.

Type

All sections

Senior editors

Matthias Barton

University of Zurich, Switzerland

Matthias Barton, MD, is a Professor of Cardiology at the University of Zurich. His clinical and investigative focus are general cardiology and preventive medicine, with a particular interest in coronary artery disease and myocardial infarction. His work explores mechanisms of atherosclerosis, heart disease in women, and vascular factors contributing to cardiovascular health and disease.

Expertise
Medicine

Research focus
cardiovascular medicine
coronary artery disease
vascular biology
heart disease in women
molecular medicine

Competing interests statement
Matthias Barton has received funding from the Swiss National Science Foundation and is on the editorial boards of the American Journal of Cardiovascular Disease, the American Journal of Physiology Regulatory Integrative & Comparative Physiology, Endocrine and Metabolic Science, Experimental Biology and Medicine, Arteriosclerosis, Thrombosis and Vascular Biology and Hypertension, official journals of the American Heart Association. He has been an elected ordinary member of the Academy of Europe (Academia Europaea) since 2017.
Balram Bhargava

Indian Council of Medical Research, India

Dr Bhargava is the Director General of the Indian Council of Medical Research (ICMR) Secretary, Department of Health Research, (Ministry of Health & Family Welfare), Government of India.

Professor (Dr) Balram Bhargava was born in Lucknow 21st July 1961. He received all his medical training at the King George Medical College, Lucknow. Further, he received advanced training at the Gardiner Institute, University of Glasgow and the Washington Heart Centre, Washington DC.

Balram Bhargava is Professor of Cardiology at the All India Institute of Medical Sciences, New Delhi, and also serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB).

He is a cardiologist at the forefront of biomedical innovation, public health, medical education, and medical research. He directs the School of International Biodesign at AIIMS, an interdisciplinary programme to foster innovation and design of low-cost implants and devices which has led to more than thirty patents on low-cost medical devices and a dozen start-ups. He developed the indigenous Platinum Iridium coil coronary stent and has been instrumental in clinically evaluating and establishing medicated Indian stents. He has led innovations initiatives, such as Society for Less Investigative Medicine (SLIM). He is currently providing leadership for creative disease prevention, early detection, and transport system for sick cardiac patients (mission DELHI (Delhi Emergency Life Heart-Attack Initiative) by trained motorcycle first responder Paramedics).

Professor Bhargava was awarded the Padma Shri by the Indian government for his contributions to medicine. He is also been awarded the SN Bose Centenary Award by the Indian National Science Congress, the National Academy of Sciences Platinum Jubilee Award, the Tata Innovation Fellowship, Vasvik Award for Biomedical Technology Innovation, the Ranbaxy Award, OP Bhasin Award in the field of Health and Medical Sciences and more recently the UNESCO Equatorial Guinea Prize for Life Sciences. Dr Lee Jong-Wook Memorial Prize for Public Health, 2019 by WHO Hqrs, Geneva and received President’s Medal Award from Royal College of Physicians and Surgeons of Glasgow, UK for his research in ‘Frugal Innovations’ in February 2020.

Expertise
Medicine
Epidemiology and Global Health

Research focus
interventional cardiology
stents
restenosis
coronary artery disease
risk factors of valvular heart disease
interventions of rheumatic heart disease
epidemiology
non-communicable disease
infectious disease
health policy
public health

Experimental organism
human

Competing interests statement
Dr Bhargava is the founding editor of the British Medical Journal Innovations (BMJi) until 2018, and he is currently the Editor-in-Chief of the Indian Journal of Medical Research.
Christian Büchel

University Medical Center Hamburg-Eppendorf, Germany

Christian Büchel is a member of the Hamburg Center for Neuroscience in Hamburg, where he is also the Director of the Department for Systems Neuroscience at Hamburg University Medical Center. He holds an Affiliate Professor appointment in the Psychology department at the University of Hamburg. After Medical School at the University of Heidelberg, he performed postdoctoral research with Karl Friston as a Wellcome Research Fellow at the Wellcome Department of Imaging Neuroscience at UCL in London with a focus on effective connectivity.

Establishing his lab in Hamburg, he focused on the cognitive neuroscience of pain and motivation and initially studied decision making with an emphasis on delay discounting. In a parallel stream of projects he observed that the pain modulation underlying placebo analgesia can already be observed at the spinal cord level, a finding which he later also established for nocebo hyperalgesia. He is part of the IMAGEN study and during his time at Stanford he identified hypoactivation of reward circuits as a potential risk factor for addiction.

He is a member of the Academy of Science in Hamburg and was awarded the Jung Award for Medicine, the Gottfried Wilhelm Leibniz-Preis by the German Research Foundation, and the Wiley Young Investigator Award of the Organization for Human Brain Mapping for recognition of his work in cognitive neuroscience.

Expertise
Neuroscience
Medicine

Research focus
cognitive neuroscience
pain modulation
decision-making
fear
anxiety
addiction

Experimental organism
human

Competing interests statement
Christian Büchel has received research grants from the European Research Council, Deutsche Forschungsgemeinschaft and Bundesministerium für Bildung und Forschung. He serves on the board of reviewing editors of Science magazine. He serves on the Swiss National Research Council, the Scientific Advisory Board of the ICM in Paris and the Center for Behavioral Brain Sciences, Magdeburg, Germany.
Nancy Carrasco

Vanderbilt University School of Medicine, United States

Nancy Carrasco is the Joe C. Davis Professor and Chair of the Department of Molecular Physiology and Biophysics at the Vanderbilt University School of Medicine. She obtained her MD and Master’s in Biochemistry from the National Autonomous University of Mexico in her native Mexico City. Dr Carrasco did her postdoctoral work at the Roche Institute of Molecular Biology in New Jersey, for which she received a Fogarty International Fellowship. She then joined the Department of Molecular Pharmacology at the Albert Einstein College of Medicine, and later the Department of Cellular and Molecular Physiology at the Yale School of Medicine. Dr Carrasco has a longstanding interest in transport across biological membranes and in the role of membrane proteins in physiology and pathophysiology. Her cloning of the sodium/iodide symporter (NIS) has had numerous ramifications for many other fields, including structure/function of transport proteins, molecular endocrinology, gene transfer studies, cancer, and public health (she has served on the EPA’s Science Advisory Board). She has received numerous awards, including the Pew Award; the Arnold and Mabel Beckman Foundation Award; the Maria Sibylla Merian Award (Germany); the Merck Prize from the European Thyroid Association (Poland); the Rose Pitt-Rivers Lectureship at the British Endocrine Society Meeting (Scotland); the Noun Shavit Award (Israel); the Marshall S. Horwitz Faculty Prize for Research Excellence; and the Light of Life Award. She has served as president of the Society of Latin American Biophysicists. Dr Carrasco was elected to the National Academy of Sciences in 2015 and to the National Academy of Medicine in 2020.

Expertise
Medicine
Biochemistry and Chemical Biology
Structural Biology and Molecular Biophysics

Research focus
molecular endocrinology
biochemistry of membrane proteins
biophysics of membrane proteins
mechanistic information of NIS
regulation of NIS
sodium/iodide symporter
cross-talk between hormones
metabolism

Experimental organism
mouse
human

Competing interests statement
Dr Carrasco’s research has been funded by NIH. She is on the NICHD Board of Scientific Counselors.
Miles P Davenport

University of New South Wales, Australia

Miles Davenport is Professor of Medicine and Head of the Infection Analytics Program at the Kirby Institute for Infection and Immunity at UNSW Sydney. He graduated in medicine from the University of Sydney and completed his DPhil at the University of Oxford in immunology before retraining in mathematical biology. He leads a team of applied mathematicians who use statistical analysis and modelling to understand host-pathogen interactions in infection and immunity. This involves collaboration with a wide variety of experimental and clinical scientists both in Australian and internationally. Major areas of investigation include understanding HIV latency, malaria immunity and treatment, and neonatal immune development. He is a past-President of the Australasian Society for Immunology and is supported by an NHMRC (Australia) Investigator grant.

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Epidemiology and Global Health
Medicine

Research focus
virology
immunity
vaccines
HIV/AIDS
mathematical modelling
host-pathogen interactions
biostatistics

Competing interests statement
Miles Davenport receives funding from the National Health and Medical Research Council (Australia), the Australian Research Council, and the National Institutes of Health (USA). He is an Associate Editor at PLoS Computational Biology and on the Editorial Board of Immunology and Cell Biology.
Betty Diamond

The Feinstein Institute for Medical Research, United States

Betty Diamond received an MD from Harvard Medical School. She performed a residency in Internal Medicine at Columbia Presbyterian Medical Center, and then a post-doctoral fellowship in Immunology with Dr Matthew Scharff at the Albert Einstein College of Medicine. She is currently Director of the Institute of Molecular Medicine at the Feinstein Institute for Medical Research.

Dr Diamond’s research has focused on the induction and pathogenicity of anti-DNA antibodies in Systemic Lupus Erythematosus. She showed that somatic mutation of immunoglobulin genes can generate autoantibodies in mice and humans, making the germinal center a focus in disease pathogenesis. Her laboratory has also demonstrated that a subset of anti-DNA antibodies cross-reacts with the NMDA receptor and showed that autoantibodies can cause aspects of neuropsychiatric lupus, creating a paradigm for antibody-mediated changes in brain function in many conditions. Most recently, she has developed a research program on the immunomodulatory functions of C1q.

She received the Outstanding Investigator Award of the ACR in 2001, the Lee Howley Award from the Arthritis Foundation in 2002, and the Recognition Award from the National Association of MD-PhD Programs in 2004 and the AAI Distinguished Fellow Award in 2019. In 2006, she was elected to the Institute of Medicine and became a fellow of the AAAS. She has served on the Scientific Council of NIAMS and the Board of Directors of the American College of Rheumatology. She is a past President of the American Association of Immunologists.

Expertise
Medicine
Immunology and Inflammation

Research focus
B cells
systemic lupus
neuropsychiatric lupus
autoantibodies
autoimmunity

Experimental organism
human
mouse

Competing interests statement
Betty Diamond receives funding from the NIH, LuCIN (Lupus Clinical Investigators Network), Lupus Research Alliance, DOD Lupus and Leidos Biomedical Research, Inc.. She is the Chief Editor at Molecular Medicine and a Deputy Editor for Frontiers in Immunology.
Wafik S El-Deiry

Brown University, United States

Wafik El-Deiry, MD, PhD, FACP is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director, Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown and Lifespan. He is a Professor of Pathology and Laboratory Medicine, Professor of Medical Science, and Mencoff Family University Professor at Brown. He sees patients in his weekly clinic at Rhode Island Hospital focused on care of patients with colorectal cancer and participates in clinical trials based on his laboratory’s research on novel therapeutics. He previously served as Deputy Director for Translational Research, co-Leader of the Molecular Therapeutics Program, Professor of Oncology, and the William Wikoff Smith Endowed Chair in Cancer Research at Fox Chase Cancer Center. From 2010 through 2014 Dr El-Deiry was the Rose Dunlap Professor of Medicine and Chief of Hematology-Oncology at Penn State. In 2009, El-Deiry became an American Cancer Society Research Professor. He was previously a tenured Professor of Medicine (Hematology-Oncology), Genetics, and Pharmacology at University of Pennsylvania, co-Leader of the Radiobiology and Imaging Program at the Abramson Cancer Center and Associate Director for Physician-Scientist Training in Hematology-Oncology when he left Penn in 2010. He earned MD/PhD degrees from University of Miami School of Medicine and completed internal medicine residency and medical oncology fellowship at the Johns Hopkins Hospital and the Johns Hopkins Oncology Center. As a practicing academic Oncologist, his scientific interest and expertise is in cell death, drug resistance in cancer and drug discovery and development. El-Deiry founded two companies, Oncoceutics, Inc. and p53-Therapeutics, Inc.

El-Deiry discovered p21(WAF1) as a p53 target gene, universal cell cycle inhibitor, and tumor suppressor gene that for the first time explained the mammalian cell stress response. He discovered TRAIL receptor DR5 and its regulation by p53. TRAIL is part of the host immune system that suppresses cancer and its metastases. His lab created a knock-out mouse for TRAIL receptor DR5 and this mouse is tumor prone and develops an inflammatory syndrome in the lungs and gut after sub-lethal irradiation. He identified c-Myc as a major determinant of TRAIL sensitivity and demonstrated synergy between TRAIL therapy and multi-kinase inhibitor sorafenib. Building on his prior accomplishments, El-Deiry discovered ONC201/TIC10 as a first-in-class TRAIL pathway inducer that is orally bioavailable and crosses the blood-brain barrier to treat brain tumors. TRAIL and Foxo3a are required for the anti-tumor effect of ONC201 through dual blockade of ERK and Akt kinases that promotes the nuclear translocation of the Foxo3a transcription factor which directly regulates the TRAIL gene. Data from El-Deiry’s lab identified that ONC201 induces TRAIL receptor DR5 through an integrated stress response involving ATF4 and CHOP transcription factors. Patients with among the most aggressive gliomas (H3K27M mutant DIPG) have had exceptional responses to ONC201.

As a physician-scientist, Dr El-Deiry has worked to bring new discoveries to the clinic. He is committed in the next phase of his career to unraveling the mechanisms involved in p53 pathway restoration by candidate therapeutics his lab has discovered. This is exciting as he is defining a novel class of anti-cancer drugs with p53 pathway restoration and S-phase checkpoint targeting and recognizing ATF4 as a major transcription factor mechanism for p53 pathway restoration in p53-null or p53 mutant tumor cells. He is establishing transcriptomic and proteomic data sets with chemotherapy that acts through p53, and with novel small molecules that restore the p53 pathway in p53-deficient or mutant p53 expressing cells. He is exploiting medicinal chemistry and organoid technologies to perform his translational science that is leading to clinical trials some of which he leads. Dr El-Deiry conducts basic and translational clinical oncology therapeutics research through funded NIH grants, Foundations and industry. He is a member of the ASCI, AAP, Past President of the Interurban Clinical Club, previous Chair of ASCO’s Tumor Biology Track, and past Chair of an NIH Study Section on Cancer Therapeutics. Dr El-Deiry has trained many students and post-doctoral fellows, physician-scientists, and continues to mentor junior scientists and faculty in basic and translational cancer research.

Expertise
Medicine
Cancer Biology

Research focus
cancer
tumor suppressor genes
colorectal cancer
p53 pathway
cell death
medical oncology
drug development
drug discovery
p21(WAF1)
ONC201/TIC10
physician-scientist issues

Experimental organism
human
mouse

Competing interests statement
Dr El-Deiry receives funding from the NIH/NCI, the Warren Alpert Foundation, and D&D Pharmatech. He is a Specialty Chief Editor for the Cancer Molecular Targets and Therapeutics Section of Frontiers in Oncology. He is also a Section Editor for Molecular Oncology and HemOnc Today. Dr El-Deiry is the scientific founder and shareholder of Oncoceutics, Inc. and p53-Therapeutics, Inc.
Eduardo Franco

McGill University, Canada

Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.

Expertise
Cancer Biology
Epidemiology and Global Health
Medicine

Research focus
cancer epidemiology
cancer prevention
human papillomavirus
cancer screening

Experimental organism
human

Competing interests statement
Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
Wendy S Garrett

Harvard T.H. Chan School of Public Health, United States

Wendy Garrett is a Professor of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health, co-Director of the Harvard Chan Center for the Microbiome in Public Health, and an Associate Member of the Broad Institute. Her work explores host-microbiota interactions underlying mucosal immune homeostasis, gastrointestinal inflammatory disorders, and cancer. She graduated from the Yale College; received her MD PhD from Yale University and completed post-graduate training at Harvard.

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Medicine

Research focus
host-microbiota interactions
microbiome
mucosal immunology

Competing interests statement
Wendy Garrett serves on advisory boards of Evelo Biosciences, Kintai Therapeutics, and Leap Therapeutics. She is a member of the Cell Reports and Journal of Clinical Microbiology editorial boards.
Diane M Harper

University of Michigan, United States

Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.

She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.

She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.

While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the sentinel clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.

Expertise
Medicine
Epidemiology and Global Health
Microbiology and Infectious Disease
Immunology and Inflammation

Research focus
HPV associated diseases
primary care
women's health
cancer precursor detection
health behaviours
epidemiology
cancer screening

Experimental organism
human

Competing interests statement
Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
Carlos Isales

Medical College of Georgia at Augusta University, United States

Carlos Isales is from San Juan, Puerto Rico, where he graduated from the University of Puerto Rico School of Medicine and did his residency in Internal Medicine at the San Juan Veterans Administration Hospital. He completed a fellowship in Endocrinology and Metabolism at Yale University School of Medicine working in a laboratory under Dr Howard Rasmussen. In 1993, he moved to the Medical College of Georgia in Augusta, GA to help establish the Institute of Molecular Medicine and Genetics. His work has focused on defining the impact of nutrients on bone metabolism and loss of nutrient sensing with aging leading to both bone and muscle loss. His group was among the first to characterize an entero-osseous axis linking incretin hormones and bone turnover. Current work is focused on defining the impact of oxidation of aromatic amino acids and downstream metabolites such as tryptophan-kynurenine on stem cell proliferation and differentiation and resultant age-related osteoporosis. He is currently Chief of the Division of Endocrinology and Metabolism at Augusta University, Regents’ Professor and J. Harold Harrison Distinguished University Chair in Healthy Aging. He is also the Clinical Director of the newly established Center for Healthy Aging. His research is funded by the National Institutes of Aging. He is also passionate about mentoring the next generation of scientists and is MPI on a training award from the National Institutes on Aging.

Expertise
Medicine

Research focus
aging
stem cells
epigenetics
metabolic bone disease
nutrition
amino acid metabolism
tryptophan metabolism

Experimental organism
human
mouse

Competing interests statement
Carlos Isales is currently funded by the National Institute on Aging. He is co-founder of Gerologix, a company focused on developing countermeasures to musculoskeletal aging. He is currently Academic Editor for PLOS ONE and JBMR Plus.
Y M Dennis Lo

The Chinese University of Hong Kong, Hong Kong SAR China

Dennis Lo is the Li Ka Shing Professor of Medicine and Director of the Li Ka Shing Institute of Health Sciences at The Chinese University of Hong Kong. He received his BA (Hons) from the University of Cambridge and his Doctor of Medicine and Doctor of Philosophy degrees from the University of Oxford. He discovered the presence of cell-free fetal DNA in maternal plasma in 1997. He has since translated this finding into a platform for noninvasive prenatal testing (NIPT). He has also made concurrent discoveries and inventions in the liquid biopsies of cancer. In recognition of his work, he has been elected as a Fellow of the Royal Society (UK), Foreign Associate of the US National Academy of Sciences, Fellow of the World Academy of Sciences and a founding member of the Hong Kong Academy of Sciences. He is a recipient of the Breakthrough Prize in Life Sciences (2021).

Expertise
Medicine
Genetics and Genomics

Research focus
molecular diagnostics
prenatal diagnosis
biomarkers in oncology
clinical genomics
noninvasive prenatal testing
cancer screening with liquid biopsy

Experimental organism
human
mouse

Competing interests statement
Research funding from the Hong Kong Research Grants Council, Innovation and Technology Commission and Li Ka Shing Foundation. Trustee of the Croucher Foundation. Commercial relationships including licensing, equity or consultancy: Grail, Illumina, Sequenom, Xcelom, DRA, Take2 and Decheng Capital. Associate editorship of journals: Clinical Chemistry, npj Genomic Medicine. Memberships of journal editorial boards: Journal of Pathology, Philosophical Transactions of the Royal Society B, Journal of Genomes and Exomes, Disease Markers and Marrow.
Paul W Noble

Cedars-Sinai Medical Centre, United States

Paul W Noble, MD is a physician-scientist at the Cedars-Sinai Medical Center in Los Angeles where he is a Professor of Medicine and Chair of the Department of Medicine. He attended Haverford College and received his MD from New York University. After internal medicine residency and chief residency, he trained in pulmonary and critical care medicine at the University of Colorado and the National Jewish Center in Denver where he did his research fellowship with David Riches and Peter Henson and gained expertise in interstitial lung diseases. He has held faculty positions at the Johns Hopkins Hospital and Yale University School of Medicine where he was a tenured Professor and started the interstitial lung disease clinics at both institutions. He then moved to Duke University where he was a tenured Professor and Chief of the Division of Pulmonary, Allergy and Critical Medicine before moving to Cedars-Sinai in 2013.

His laboratory has focused on the cellular and molecular mechanisms of unremitting lung inflammation and fibrosis. He defined the roles of endogenous matrix degradation products and host defense in regulating persistent lung inflammation. Over the last decade he has focused on mechanisms the lead to fibroblast activation and invasion in severe pulmonary fibrosis and the failure of alveolar progenitor cell renewal in idiopathic pulmonary fibrosis (IPF). He has also played a significant role in the clinical trial development of the only FDA-approved treatments for IPF. He still maintains an active clinical practice. His laboratory has been funded by the NIH since 1992. He is an elected member of the American Society of Clinical Investigation, Interurban Clinical Club and the Association of American Physicians where he currently serves on Council.

Expertise
Medicine

Research focus
pulmonary medicine
critical care
lung inflammation
fibrosis
host defense
clinical trials
epithelial cell biology
fibroblast biology

Experimental organism
human
mouse

Competing interests statement
The Noble Laboratory is supported by the National Institutes of Health (National Heart, Lung and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID).
Groesbeck Parham

University of Zambia, Zambia
University of North Carolina, Chapel Hill, United States

Dr Groesbeck Parham earned his BS in Sociology/Anthropology from Oberlin College and MD from the University of Alabama at Birmingham, where he completed a residency in Obstetrics and Gynecology. He pursued studies in female urology at the University of London, England (St. George’s Hospital) and the University of Khartoum, Sudan, where he studied surgical techniques to repair pelvic defects in women who had undergone genital mutilation (circumcision).

Afterwards completing a fellowship in gynecologic oncology at the University of California, Irvine, Dr Parham served as director of the divisions of Gynecologic Oncology at the Charles Drew University of Medicine and Science in Los Angeles and at the University of Arkansas School of Medicine in Little Rock. He established the first gynecology clinic for HIV-infected women in southern California, located at T.H.E. Clinic in Los, Angeles. Presently, he is professor of gynecologic oncology at the University of North Carolina at Chapel Hill. In Lusaka, Zambia, where he has lived since 2005, he serves as Honorary Consultant and Lecturer at the University Teaching Hospital of Zambia where he leads a surgical training program in gynecologic oncology. His expertise in scaling up cervical and breast cancer services in resource-poor global environments has been sought by the United Nations Population Fund and World Health Organization, where he presently serves as the Senior Clinical Expert for the Elimination of Cervical Cancer in the Office of the Director General.

As a leader in combating women’s cancers in resource-constrained global environments, he developed an innovative program (Cervical Cancer Prevention Program in Zambia) for cervical cancer screening in which trained nurses use simple household vinegar and a digital camera. More than 1 million Zambian women have been screened by the program, it has been adopted by the Zambian Ministry of Health, and has been leveraged to facilitate solutions for downstaging breast cancer in Africa. His many honors include awards from the Society of Gynecologic Oncology, the Congressional Black Caucus, the United Nations and honorary doctorate degrees from Oberlin College and Southern Methodist University.

Expertise
Medicine

Research focus
gynecologic oncology
women's health
breast cancer
HIV
cervical cancer
cervical cancer screening in Africa
cancer control in resource-constrained environments
virtual reality surgical simulation

Competing interests statement
Groesbeck Parham has received funding from NCI, CDC, IARC, and international philanthropic organizations, including the Susan G. Komen Foundation, Howard G. Buffett Foundation, Dikembe Mutombo Foundation, CHAI, ICAP, IARC, MRC-UK. He is a peer reviewer for Cancer, Obstetrics and Gynecology, Gynecologic Oncology, Journal of Lower Genital Tract Disease, among other journals.
Jos WM van der Meer

Radboud University Medical Centre, Netherlands

Jos WM van der Meer is emeritus Professor of Medicine at Radboud University Nijmegen, The Netherlands. Between 1992 and 2012 he was head of the Department of internal medicine at the Radboud University Medical Centre. His major areas of expertise are host defence against infection, trained immunity, autoinflammation, immunodeficiency and antimicrobial policy.

Expertise
Medicine
Microbiology and Infectious Disease

Research focus
infectious disease and host defense
innate immunity
trained immunity
immunodeficiency
autoinflammatory diseases
chronic fatigue syndrome

Experimental organism
human
mouse

Competing interests statement
Jos WM van der Meer is a member of the Royal Netherlands Academy of Arts and Sciences (KNAW), for which he served as a vice-president from 2005 to 2011. He is a member of Academia Europaea and he is past-president of EASAC, the European Academies Science Advisory Council. He is an honorary Fellow of the Royal College of Physicians in London and in Edinburgh and a fellow of the Infectious Diseases Society of America and of the European Society of Clinical Microbiology and Infectious diseases. He is a member of the Dutch National Board for Research Integrity LOWI. He received a number of prices and awards, such as the Gold Hijmans van den Bergh medal. He was awarded knighthood in the order of the Netherlands Lion in 2003.
Gary Westbrook

Vollum Institute, United States

Gary Westbrook is a Senior Scientist at the Vollum Institute and Rocky and Julie Dixon Professor of Neurology at Oregon Health & Science University. Dr. Westbrook is a member of the National Academy of Medicine (formerly Institute of Medicine), the American Academy of Arts and Sciences, and past editor-in-chief of the Journal of Neuroscience. He has received Javits and Merit awards from NIH for his research as well as an International Cooperation Award from the Max Planck Society. Dr. Westbrook received his medical training and did graduate study in Biomedical Engineering at Case Western Reserve University, followed by residencies in Internal Medicine and Neurology, and basic neuroscience research at the National Institutes of Health in Bethesda. Earlier work in his lab was mostly directed at the level of receptors, particularly N-methyl-D-aspartate (NMDA) receptors, and the function of single synapses. The emphasis has now largely shifted to studies of small networks (microcircuits) in the hippocampus. Dr. Westbrook maintains interests in clinical neurology, particularly epilepsy, as well as graduate research training. He was co-Director of the Vollum Institute (2005-2015) and director of the Neuroscience Graduate Program at Vollum/OHSU (2008-2018).

Expertise
Neuroscience
Medicine

Research focus
synaptic transmission
synaptic plasticity
ligand-gated ion channels
hippocampus
olfactory bulb
epilepsy
in vitro physiology
activity-dependent gene expression

Experimental organism
mouse

Competing interests statement
Gary Westbrook is employed by Oregon Health and Science University. He receives research and training funding from the National Institutes of Health and the Ellison Medical Foundation. He is a member of the National Academy of Medicine (formerly Institute of Medicine) and the American Academy of Arts and Sciences. He serves on Scientific Advisory Boards for Max Planck Institutes in Göttingen (MPIEM) and Florida (MPFI), the Myelin Repair Foundation, and on study sections for the National Institutes of Health. He is currently a member of editorial boards for Physiological Reviews and Philosophical Transactions of the Royal Society B.
Richard M White

Memorial Sloan Kettering Cancer Center, United States

Richard White, M.D., Ph.D, is a physician-scientist at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. He is interested in basic mechanisms underlying metastasis, using the zebrafish as a model system. His work has established numerous techniques for cancer modeling and high-resolution imaging in the fish. Using these tools, the lab is focused on the cross-talk between tumor cells and the microenvironment, and how this interplay influences metastatic success. His work has revealed novel interactions between melanoma cells and adipocytes in the microenvironment, and how neural crest programs play roles in melanoma progression. He has been awarded the NIH Director’s New Innovator Award, the Pershing Square Foundation Award, and the Mark Foundation ASPIRE award.

Expertise
Cancer Biology
Cell Biology
Developmental Biology
Medicine

Research focus
development
neural crest
zebrafish
cancer
melanoma
metastasis
microenvironment

Experimental organism
zebrafish

Competing interests statement
Richard White receives funding from the National Institutes of Health, the Pershing Square Sohn Foundation, the Mark Foundation, the Melanoma Research Alliance, the American Cancer Society and the Harry J. Lloyd Foundation. He receives consulting fees from N-of-One, Inc.
Ma-Li Wong

State University of New York Upstate Medical University, United States

Ma-Li Wong, MD, PhD, FRANZCP, is Professor in the Department of Psychiatry and Behavioral Sciences, and Neurosciences and Physiology at SUNY Upstate Medical University. She was born in Hong Kong and grew up in Brazil, where she graduated from the University of São Paulo School of Medicine (FMUSP). She had clinical and research training in psychiatry at Albert Einstein College of Medicine, NIH, and Yale University. Ma-Li Wong is a bench, clinical and translational researcher in the biology of depression and co-morbid conditions, chronic stress, and antidepressant drugs. She has conducted research for over 30 years at Yale (Chief Resident and Instructor), National Institutes of Health (Unit Chief), University of California, Los Angeles (Professor), University of Miami (Professor and Vice-Chair), and in Australia (Australian National University, South Australian Health and Medical Research Institute, and Flinders University). She was the recipient of the following awards: Milton Rosenbaum Award for Psychiatric Research (1989); Lilly Psychiatric Research Fellowship by the American Psychiatric Association (1990); SmithKline Beecham Award by the Society of Biological Psychiatry (1990); APA/Dista Research Award (1993); NIH Fare Award (1996 and 1997); Henry L. Moses Award by the Montefiore Medical Center (1998). She co-edited two books: Pharmacogenomics: The Search for Individualized Therapeutics (2002) and Biology of Depression: From Novel Insights to Therapeutic Strategies (2005).

Expertise
Medicine
Neuroscience

Research focus
major depression
chronic stress
neuroinflammation
neuroendocrinology
pharmacogenomics
genetics
obesity
leptin

Experimental organism
human
mouse
primary cells
immortalized cells

Competing interests statement
Ma-Li Wong is an Associate Editor for Molecular Psychiatry. She has been funded by organizations such as the NIH in the US and the National Health and Medical Research Council in Australia.
Mone Zaidi

Icahn School of Medicine at Mount Sinai, United States

Mone Zaidi graduated in medicine from King George’s Medical College, India, and trained clinically at the Hammersmith Hospital, London, under the tutelage of Iain MacIntyre, FRS. After obtaining a PhD and MD from the University of London, Dr Zaidi held appointments as Lecturer at the Royal Postgraduate Medical School and Senior Lecturer and Honorary Consultant at St. George’s Hospital Medical School for over 8 years. In 1999, he moved to Mount Sinai School of Medicine in New York as Professor of Medicine and Founding Director of The Mount Sinai Bone Program. Zaidi has discovered mechanisms of skeletal homeostasis in health and its dysregulation in common and rare diseases. These studies, spanning over 30 years, included the first description of calcium sensing in the osteoclast and the discovery that locally released nitric oxide acts to suppress bone removal. In 2003, his group published evidence for a pituitary–bone axis of medical significance, in which pituitary hormones affect the skeleton directly. More recently, he found that inhibiting FSH not only increased bone mass, but also reduced body fat and increased thermogenesis – in essence, laying the firm foundation for his new humanized monoclonal FSH antibody to treat both osteoporosis and obesity. This corpus of work was selected by Nature Medicine as one of eight “Notable Advances” in biomedicine for 2017. Zaidi’s research was funded by the Medical Research Council of the UK, and since 1997, by the US National Institutes of Health. He is an elected member of the American Society for Clinical Investigation, Association of American Physicians, the Interurban Clinical Club (established by Sir William Osler in 1905) of which he was President, the Practitioners’ Society of New York (the oldest medical society in the US), and the Association of Professors of Medicine. Zaidi was made Master of the American College of Physicians, received the Harrington Scholar-Innovator Award, was elected as Fellow of the American Association of Advancement of Science, and is recipient of three honorary doctorates.

Expertise
Medicine

Research focus
osteoporosis
obesity
bone mass
metabolism
adipose tissue
endocrine physiology
pituitary hormones
FSH

Competing interests statement
Mone Zaidi is currently funded by the National Institute on Aging and the National Institute of Diabetes, Digestive and Kidney Diseases of the NIH. He is inventor on several patents in relation to his work on FSH, bone and body composition. He is currently Consulting Editor for the Journal of Clinical Investigation, Editor of a series – Marrow – of the Annals of the New York Academy of Sciences, and Editor-in-chief of the Encyclopedia of Bone Biology, published by Elsevier as their Major Reference Works.
Huda Zoghbi

Baylor College of Medicine and Texas Children's Hospital, United States, United States

Huda Zoghbi is Professor of Pediatrics, Neurology, Molecular and Human Genetics, and Neuroscience at Baylor College of Medicine, Houston, Texas. She is also an Investigator with the Howard Hughes Medical Institute and Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. Her research focuses on understanding normal brain development and on elucidating the pathogenesis of several neurological disorders including the autism spectrum disorder, Rett syndrome, and late-onset neurodegenerative diseases.

Expertise
Neuroscience
Genetics and Genomics
Medicine

Research focus
neurobiology of disease
neurodegeneration
autism
ataxia

Experimental organism
human
mouse

Competing interests statement
Huda Zoghbi is actively receiving funds from the Howard Hughes Medical Institute, the National Institutes of Health, Rett Syndrome Research Trust, International Rett syndrome Foundation (and she is a member of advisory panels for all four organizations), Baylor College of Medicine, and Texas Children’s Hospital. She is Editor-in-chief of Annual Reviews of Neuroscience and a member of the editorial team of Cell and Neuron. She is immediate past President of the McKnight Neuroscience Fund and a member of the following Scientific Advisory Panels: Shaw Prize Jury, Breakthrough Prize Jury, and Vilcek Prize Jury; and a member of the Scientific Advisory Board of Denali Therapeutics and The Column Group. She is also a member of Regeneron’s Board.

Reviewing editors

Jonathan Abraham

Harvard Medical School, United States

Expertise
Biochemistry and Chemical Biology
Structural Biology and Molecular Biophysics
Microbiology and Infectious Disease
Medicine

Research focus
emerging viruses
antibody neutralisation
viral entry
viral replication
x-ray crystallography
cryo-EM
Cheryl Ackert-Bicknell

University of Colorado, United States

Expertise
Medicine
Genetics and Genomics

Research focus
bone
bone biology
genetics
musculoskeletal
aging

Experimental organism
mouse
rat
Anurag Agrawal

CSIR Institute of Genomics and Integrative Biology, India

Expertise
Medicine

Research focus
asthma
respiratory diseases

Experimental organism
human
mouse
David B Allison

Indiana University, United States

Expertise
Medicine
Genetics and Genomics
Epidemiology and Global Health
Computational and Systems Biology
Evolutionary Biology

Research focus
experimental design
statistics
longevity
biostatistics
obesity
nutrition
senescence
research rigour
science integrity
Hossein Ardehali

Northwestern University, United States

Expertise
Medicine
Biochemistry and Chemical Biology

Research focus
mitochondria
iron
glucose metabolism
mRNA-binding proteins
hexokinases
metabolism
cardiac biology
Audrey M Bernstein

State University of New York Upstate Medical University, United States

Expertise
Cell Biology
Medicine

Research focus
cornea
scarring
fibrosis
glaucoma
integrins
myofibroblast
Annelien Bredenoord

University Medical Centre Utrecht, Netherlands

Expertise
Medicine

Research focus
bioethics
medical ethics
ethics
Xuetao Cao

Zhejiang University School of Medicine, China

Expertise
Cancer Biology
Immunology and Inflammation
Medicine

Research focus
immunology of APCs
TLR signalling and immune regulation
cancer immunotherapy and gene therapy
Howard Y Chang

Stanford University, United States

Expertise
Medicine
Chromosomes and Gene Expression
Genetics and Genomics

Research focus
cancer
immunotherapy
RNA
genomics
epigenomics
dermatology

Experimental organism
human
mouse
Murim Choi

Seoul National University College of Medicine, South Korea

Expertise
Genetics and Genomics
Medicine

Research focus
rare diseases
neurodevelopmental disorders
functional characterization of genetic variants
bioinformatics
Mendelian genetics
Sarah E Cobey

University of Chicago, United States

Expertise
Microbiology and Infectious Disease
Ecology
Evolutionary Biology
Epidemiology and Global Health
Medicine

Research focus
B cells
coevolution
infectious disease dynamics
influenza
mathematical modelling
vaccination
Yali Cong

Peking University Health Science Center, China

Expertise
Medicine

Research focus
medical ethics
bioethics
Alex R Cook

National University of Singapore, Singapore

Expertise
Epidemiology and Global Health
Microbiology and Infectious Disease
Medicine

Research focus
infectious disease epidemiology
mathematical modelling
biostatistics
health policy
Seth J Corey

Cleveland Clinic, United States

Expertise
Cancer Biology
Medicine

Research focus
myeloid malignancies
inherited or acquired bone marrow failure
neutrophils
platelets zebrafish
cancer evolution
proteostasis
Ralph J DeBerardinis

University of Texas Southwestern Medical Center, United States

Expertise
Cancer Biology
Cell Biology
Medicine

Research focus
metabolism
cancer
genetics
medicine
pediatrics
genomics
mitochondria

Experimental organism
human
mouse
Anna Mae Diehl

Duke University School of Medicine, United States

Expertise
Medicine

Research focus
gastroenterology
hepatology
Ana Domingos

University of Oxford, United Kingdom

Expertise
Medicine
Neuroscience

Research focus
metabolism
obesity
neuroimmunity
autonomic nervous system
eating behaviour
inflammation
Joel K Elmquist

UT Southwestern Medical Center, United States

Expertise
Neuroscience
Medicine
Genetics and Genomics

Research focus
metabolism
obesity
diabetes
hypothalamus
feeding
autonomic
exercise

Experimental organism
mouse
D. melanogaster
Noriaki Emoto

Kobe Pharmaceutical University, Japan

Expertise
Medicine

Research focus
cardiology
pulmonary hypertension
endothelin
pharmacology
vascular biology
Edward A Fisher

New York University Grossman School of Medicine, United States

Expertise
Medicine
Cell Biology

Research focus
preventive cardiology
cardiology
lipoprotein metabolism
atherosclerosis

Experimental organism
mouse
Jonathan Flint

University of California, Los Angeles, United States

Expertise
Genetics and Genomics
Medicine

Research focus
genetics
genomics
psychiatric disorders
Gregory G Germino

National Institute of Diabetes and Digestive and Kidney Diseases, United States

Expertise
Medicine

Research focus
nephrology
genetic renal disease
polycystic kidney disease
ciliopathies
Evangelos J Giamarellos-Bourboulis

Attikon University Hospital, Greece

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Genetics and Genomics
Medicine

Research focus
sepsis
hidradenitis suppurativa
pathogenesis of infection
biomarkers
David Ginsburg

University of Michigan, United States

Expertise
Medicine
Genetics and Genomics

Research focus
hemostasis
thrombosis
protein secretion
human genetics
fibrinolysis

Experimental organism
human
mouse
zebrafish
Joseph G Gleeson

The Rockefeller University, United States

Expertise
Medicine
Neuroscience
Developmental Biology

Research focus
neurodevelopmental disease
brain development
neurogenetics
autism
epilepsy
intellectual disability
organoid
stem cells
genomics
bioinformatics

Experimental organism
human
mouse
Michael R Green

University of Massachusetts Medical School, United States

Expertise
Cancer Biology
Chromosomes and Gene Expression
Medicine

Research focus
transcription
pre-mRNA splicing
cancer molecular biology
oncology
genetics
functional genomics

Experimental organism
human
mouse
S. cerevisiae
Timothy D Griffiths

Newcastle University, United Kingdom

Expertise
Neuroscience
Medicine

Research focus
auditory
cognition
neurology
imaging

Experimental organism
human
macaque
William C Hahn

Dana-Farber Cancer Institute, United States

Expertise
Cancer Biology
Genetics and Genomics
Medicine

Research focus
cancer
transformation
functional genomics
RAS
YAP1

Experimental organism
human
Shozeb Haider

University College London, United Kingdom

Expertise
Medicine
Structural Biology and Molecular Biophysics
Computational and Systems Biology
Microbiology and Infectious Disease

Research focus
X-ray crystallography
molecular dynamics simulations
allostery
structure-based drug design
structural bioinformatics
computational chemistry
nucleic acids
rare diseases
Sang Jun Han

Baylor College of Medicine, United States

Expertise
Medicine
Cell Biology

Research focus
nuclear receptors
steroid receptor coactivator
endometriosis
female infertility
Matthew G. Vander Heiden

Massachusetts Institute of Technology, United States

Expertise
Cancer Biology
Medicine

Research focus
cancer biology
biochemistry
metabolism
tumor microenvironment
redox biology

Experimental organism
mouse
human
Christopher L-H Huang

University of Cambridge, United Kingdom

Expertise
Medicine

Research focus
cardiac arrhythmias
atrial fibrillation
skeletal muscle
electrophysiology
ion channels
action potential propagation
genetically modified mice
patch clamping

Experimental organism
mouse
Jameel Iqbal

James J. Peters Veterans Affairs Medical Center, United States

Expertise
Medicine

Research focus
general pathology
blood banking
transfusion medicine
transplantation immunology
clinical pathology
Edward D Janus

University of Melbourne, Australia

Expertise
Epidemiology and Global Health
Medicine

Research focus
cardiovascular disease
diabetes
prevention
chronic diseases
clinical guidelines
Prabhat Jha

Saint Michael's Hospital, Canada

Expertise
Epidemiology and Global Health
Microbiology and Infectious Disease
Medicine

Research focus
epidemiology
global health
infectious disease and population dynamics
randomized controlled trials
Simon C Johnson

Seattle Children's Research Institute, United States

Expertise
Cell Biology
Medicine
Developmental Biology
Neuroscience

Research focus
mitochondria
neurodegenerative disease
aging
pediatric disease
genetic disease
mTOR
cell culture

Experimental organism
mouse
C. elegans
Gerard Karsenty

Columbia University, United States

Expertise
Genetics and Genomics
Medicine

Research focus
endocrinology
bone biology
physiology
bone endocrinology
Eunjoon Kim

Korea Advanced Institute of Science and Technology, South Korea

Expertise
Medicine
Neuroscience

Research focus
synapse adhesion and synapse development
synaptic transmission and plasticity
neurodevelopmental and neuropsychiatric disorders
autism spectrum disorders
intellectual disability

Experimental organism
mouse
rat
Melanie Königshoff

University of Colorado, United States

Expertise
Stem Cells and Regenerative Medicine
Medicine
Cell Biology

Research focus
lung regeneration
wnt signaling
pulmonary fibrosis
chronic obstructive pulmonary disease
epithelial cell biology

Experimental organism
human
mouse
Dan Larhammar

Uppsala University, Sweden

Expertise
Medicine
Evolutionary Biology
Neuroscience
Cell Biology
Chromosomes and Gene Expression
Genetics and Genomics

Research focus
evolution
gene/genome duplications
cellular and molecular neuroscience
G protein-coupled receptors (GPCR)
neuropeptides
endocrine peptides
phototransduction
ligand-gated ion channels

Experimental organism
human
zebrafish
Gabriel M Leung

The University of Hong Kong, China

Expertise
Epidemiology and Global Health
Medicine

Research focus
infectious disease epidemiology
emerging infections
population health in China and East Asia
Marc Lipsitch

Harvard T.H. Chan School of Public Health, United States

Expertise
Epidemiology and Global Health
Microbiology and Infectious Disease
Medicine

Research focus
pathogen transmission modeling
evolution of pathogens
vaccine epidemiology
antimicrobial resistance
research ethics

Experimental organism
S. pneumoniae
Paloma B Liton

Duke University School of Medicine, United States

Expertise
Medicine
Cell Biology

Research focus
ophthalmology
glaucoma
trabecular meshwork
autophagy
mechanical stretch
lysosomes
senescence
lysosomal enzymes
fibrosis
Caigang Liu

Shengjing Hospital, China Medical University, China

Expertise
Medicine
Cancer Biology

Research focus
breast cancer
translational medicine
cancer stem cells
chemotherapy drug resistance
small molecular drug screening

Experimental organism
human
mouse
Ruth Loos

The Icahn School of Medicine at Mount Sinai, United States

Expertise
Epidemiology and Global Health
Medicine
Genetics and Genomics

Research focus
genetic epidemiology
obesity
prediction
gene discovery
precision medicine

Experimental organism
human
Andrew MacPherson

University of Bern, Switzerland

Expertise
Immunology and Inflammation
Medicine

Research focus
mucosal immunity
function of IgA
mechanisms of host-microbial mutualism
Fabio Malavasi

University of Torino Medical School, Italy

Expertise
Medicine
Immunology and Inflammation

Research focus
clinical immunology
Arduino A Mangoni

Flinders Medical Centre, Australia

Expertise
Medicine

Research focus
pharmacology
drug safety
metabolomics
biomarkers
drug discovery
hypertension
Grant McArthur

Peter MacCallum Cancer Centre, Australia

Expertise
Cancer Biology
Medicine

Research focus
melanoma
Gillian J McLellan

University of Wisconsin-Madison, United States

Expertise
Medicine
Cell Biology
Neuroscience
Chromosomes and Gene Expression

Research focus
ophthalmology
pathology
imaging
glaucoma
retina
optic nerve
animal models
Jean-Pierre Michel

University of Geneva, Switzerland

Expertise
Medicine

Research focus
aging
geriatric medicine
public health
nutrition
vaccines
Subburaman Mohan

Loma Linda University, United States

Expertise
Medicine
Genetics and Genomics

Research focus
bone biology
endochondral bone formation
insulin-like growth factors
osteoporosis
osteoarthritis
skeletal development

Experimental organism
human
Zsolt Molnár

CytoSorbents Europe GmbH, Germany
University of Pécs, Hungary

Expertise
Medicine

Research focus
sepsis
septic shock
hemodynamic monitoring
fluid therapy
extracorporeal cytokine removal
Nicola Napoli

Campus Bio-Medico University of Rome, Italy

Expertise
Medicine

Research focus
endocrinology
metabolism
osteoporosis
bone fragility in diabetic reactions
diabetes
obesity
clinical trials

Experimental organism
human
Goutham Narla

University of Michigan, United States

Expertise
Medicine
Cancer Biology
Genetics and Genomics

Research focus
cancer therapeutics
cancer genetics
small molecule drug development
protein phosphatase

Experimental organism
human
mouse
Belinda Nicolau

McGill University, Canada

Expertise
Epidemiology and Global Health
Medicine

Research focus
cancer epidemiology
social determinants of health
Ole Haagen Nielsen

Herlev Hospital, University of Copenhagen, Denmark

Expertise
Medicine

Research focus
gastroenterology (especially inflammatory bowel disease)
internal medicine
Renata Pasqualini

Rutgers University, United States

Expertise
Medicine
Cancer Biology

Research focus
radiation oncology
translational cancer research
prostate cancer
vascular biology
Markus Ploner

Technische Universität München, Germany

Expertise
Neuroscience
Medicine

Research focus
pain
brain
oscillations
synchrony
electroencephalography (EEG)

Experimental organism
human
Serge Przedborski

Columbia University Medical Center, United States

Expertise
Neuroscience
Medicine

Research focus
Parkinson's disease
neurodegeneration
mitochondrial damage
motor neuron disease
amyotrophic lateral sclerosis
astrocytes
autophagy
mitophagy
necroptosis
apoptosis

Experimental organism
human
Louis Ptacek

University of California, San Francisco, United States

Expertise
Neuroscience
Medicine

Research focus
neurogenetics
circadian rhythms
sleep
episodic disorders

Experimental organism
human
mouse
Peter Ratcliffe

University of Oxford, United Kingdom

Expertise
Cell Biology
Medicine

Research focus
hypoxia
signaling
hypoxia inducible factor
prolyl hydroxylase
oxygenase
cysteine dioxygenase
von Hippel-Landau
N-degron
Isabel Rodriguez-Barraquer

University of California, San Francisco, United States

Expertise
Epidemiology and Global Health
Microbiology and Infectious Disease
Medicine

Research focus
dengue
malaria
Zika
vector-bone diseases
serology
modeling

Experimental organism
human
Antony Rosen

Johns Hopkins University School of Medicine, United States

Expertise
Medicine

Research focus
autoimmunity
autoimmune disease
rheumatic
autoantibodies
granzyme
Gian Paolo Rossi

University of Padua, Italy

Expertise
Medicine

Research focus
arterial hypertension
vascular biology
cardiology
cardiovascular medicine
endocrinology

Experimental organism
human
Charles Sawyers

Memorial Sloan-Kettering Cancer Center, United States

Expertise
Cancer Biology
Medicine

Research focus
translational medicine
oncology

Experimental organism
human
Joshua T Schiffer

Fred Hutchinson Cancer Research Center, United States

Expertise
Microbiology and Infectious Disease
Epidemiology and Global Health
Immunology and Inflammation
Medicine

Research focus
mathematical modelling
herpesviruses
HIV
COVID-19
T cell immunology

Experimental organism
human
viruses
HSV
SARS-CoV-2
Ernestina Schipani

University of Pennsylvania, United States

Expertise
Medicine
Stem Cells and Regenerative Medicine
Cell Biology
Developmental Biology
Cancer Biology

Research focus
hypoxia
hypoxia-inducible factors
mitochondria
skeleton
chondrocytes
bone
G protein-coupled receptors (GPCR)
Nicolas Schlecht

Roswell Park Comprehensive Cancer Center, United States

Expertise
Epidemiology and Global Health
Medicine

Research focus
cancer prevention
cancer control
Nima Sharifi

Cleveland Clinic, United States

Expertise
Biochemistry and Chemical Biology
Cancer Biology
Medicine

Research focus
steroid biochemistry
steroid metabolism
prostate cancer
nuclear receptors
hormone therapy resistance
androgens
oncology

Experimental organism
mouse
Dolores Shoback

University of California, San Francisco, United States

Expertise
Medicine

Research focus
endocrinology
hormones
bone metabolism
calcium
mineral
parathyroid
vitamin D

Experimental organism
human
mouse
Viviana Simon

The Icahn School of Medicine at Mount Sinai, United States

Expertise
Epidemiology and Global Health
Microbiology and Infectious Disease
Medicine

Research focus
viral-host interactions
retroviral restriction factors
HIV drug resistance
Lois Smith

Harvard Medical School, United States

Expertise
Developmental Biology
Medicine
Neuroscience

Research focus
age-related macular degeneration
diabetic eye disease
retinopathy
ocular disease

Experimental organism
mouse
Margaret Stanley

University of Cambridge, United Kingdom

Expertise
Cancer Biology
Microbiology and Infectious Disease
Medicine
Epidemiology and Global Health

Research focus
vaccines
cervix cancer
cervix precancer
keratinocyte biology
human papillomavirus
DNA viruses
vaccine immunology

Experimental organism
human
Hiroshi Takayanagi

The University of Tokyo, Japan

Expertise
Immunology and Inflammation
Medicine

Research focus
arthritis
osteoporosis
immune tolerance
osteoimmunology
autoimmunity
fibroblast
osteoclast
T cells
Kiyoshi Takeda

Osaka University, Japan

Expertise
Immunology and Inflammation
Medicine

Research focus
mucosal immunology
inflammatory bowel disease
intestinal immunity
intestinal environmental factors
intestinal epithelial cells
Sakae Tanaka

The University of Tokyo, Japan

Expertise
Medicine

Research focus
bone
osteoporosis
osteoclast
osteoarthritis
rheumatoid arthritis
orthopaedics
Rudolph E Tanzi

Harvard University, United States

Expertise
Neuroscience
Genetics and Genomics
Medicine

Research focus
Alzheimer's disease
genetics
neurodegenerative disease
amyloid
neuroinflammation

Experimental organism
mouse
human
brain organoids
J Paul Taylor

St. Jude Children's Research Hospital, United States

Expertise
Neuroscience
Cell Biology
Medicine

Research focus
liquid-liquid phase separation
RNA granules
biomolecular condensates
neurodegeneration

Experimental organism
D. melanogaster
human
M Dawn Teare

Newcastle University, United Kingdom

Expertise
Computational and Systems Biology
Epidemiology and Global Health
Medicine

Research focus
statistics
population genetics
epidemiology
Peter Tontonoz

University of California, Los Angeles, United States

Expertise
Cell Biology
Medicine

Research focus
lipid metabolism
cholesterol
nuclear receptors
adipocytes
obesity
atherosclerosis
diabetes

Experimental organism
mouse
Samra Turajlic

The Francis Crick Institute, United Kingdom

Expertise
Medicine
Cancer Biology

Research focus
medical oncology
cancer genetics
tumour heterogeneity
melanoma
kidney cancer

Experimental organism
human
Farah Usmani

United Nations Population Fund (UNFPA), United States

Expertise
Medicine

Research focus
health policy
reproductive health
reproductive rights
Frank van de Veerdonk

Radboud University Medical Center, Netherlands

Expertise
Immunology and Inflammation
Microbiology and Infectious Disease
Medicine

Research focus
medical mycology
clinical immunology
Gaël Varoquaux

INRIA, France

Expertise
Computational and Systems Biology
Neuroscience
Epidemiology and Global Health
Medicine

Research focus
machine learning
statistics
brain imaging
electronic health records
predictive models

Experimental organism
human
Jacco Wallinga

National Institute for Public Health and the Environment, Netherlands
Leiden University Medical Center, Netherlands

Expertise
Microbiology and Infectious Disease
Epidemiology and Global Health
Medicine

Research focus
modeling of infectious diseases
vaccination
infectious disease control
public health
bioinformatics
Christopher S Williams

Vanderbilt University, United States

Expertise
Medicine

Research focus
gastroenterology
GI track cancer
murine
inflammatory bowel disease
Gene W Yeo

University of California, San Diego, United States

Expertise
Chromosomes and Gene Expression
Cell Biology
Computational and Systems Biology
Genetics and Genomics
Medicine
Neuroscience
Stem Cells and Regenerative Medicine

Research focus
RNA biology
computational biology
CRISPR
neurodegeneration
single cell biology

Experimental organism
human
mouse
Hao Zhu

University of Texas Southwestern Medical Center, United States

Expertise
Cancer Biology
Stem Cells and Regenerative Medicine
Medicine

Research focus
mechanisms of tissue repair and organ regeneration
liver cancer
hepatocellular carcinoma
epigenetics
polyploidy

Experimental organism
human
mouse
Bian Zhuan

Wuhan University, China

Expertise
Medicine
Genetics and Genomics

Research focus
craniofacial genetics
oral and craniofacial developmental defects
orofacial clefts
tooth agenesis
Wilbert Zwart

Netherlands Cancer Institute, Netherlands

Expertise
Cancer Biology
Medicine

Research focus
breast cancer
prostate cancer
hormonal regulation
epigenetics
transcription factors
genomic profiling

Experimental organism
human